[1]
N. Tani, “Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study”, Multidiscip Respir Med, vol. 16, Mar. 2021, doi: 10.4081/mrm.2021.736.